Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment

Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients

(2014) Laurence Dedeken et al.   BRITISH JOURNAL OF HAEMATOLOGY

Management of Sickle Cell Disease

(2014) Barbara P. Yawn et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk Factors for Death in 632 Patients with Sickle Cell Disease in the United States and United Kingdom

(2014) Mark T. Gladwin et al.   PLoS One

The effect of hydroxcarbamide therapy on survival of children with sickle cell disease

(2013) Clarisse Lopes de Castro Lobo et al.   BRITISH JOURNAL OF HAEMATOLOGY

Sickle cell disease related mortality in the United States (1999-2009)

(2013) Dima Hamideh et al.   PEDIATRIC BLOOD & CANCER

Pulmonary Complications of Sickle Cell Disease

(2012) Andrew C. Miller et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Impact of hydroxyurea on clinical events in the BABY HUG trial

(2012) C. D. Thornburg et al.   BLOOD

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

(2011) Winfred C Wang et al.   LANCET

ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children

(2010) Mariane de Montalembert et al.   AMERICAN JOURNAL OF HEMATOLOGY

Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort

(2010) F. Bernaudin et al.   BLOOD

Improved survival of children and adolescents with sickle cell disease

(2010) C. T. Quinn et al.   BLOOD

How I use hydroxyurea to treat young patients with sickle cell anemia

(2010) R. E. Ware   BLOOD

Outcome of adults with sickle cell disease admitted to critical care - experience of a single institution in the UK

(2010) Kate Gardner et al.   BRITISH JOURNAL OF HAEMATOLOGY

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

(2009) E. Voskaridou et al.   BLOOD

An Estimation of the Incidence and Demographic Picture of the Major Hemoglobinopathies in Belgium (From a Confidential Inquiry)

(2008) Béatrice Gulbis et al.   HEMOGLOBIN

Trends in Pediatric Sickle Cell Disease-Related Mortality in the United States, 1983-2002

(2008) Emad Yanni et al.   JOURNAL OF PEDIATRICS

Hydroxyurea for Sickle Cell Disease: A Systematic Review for Efficacy and Toxicity in Children

(2008) J. J. Strouse et al.   PEDIATRICS

Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease in the First Decade of Life

(2008) T. V. Adamkiewicz et al.   PEDIATRICS